Related Experiment Video

Updated: May 22, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Metabolic monitoring training program implementation in the community setting was associated with improved monitoring

Rebecca Ronsley1, Mark Rayter, Derryck Smith

  • 1University of Toronto, Toronto, Ontario.

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|May 2, 2012
PubMed

Insights

A metabolic monitoring training program (MMTP) improved metabolic monitoring in children treated with second-generation antipsychotics (SGAs). The program also led to a significant decrease in SGA prescriptions for pediatric patients.

Area of Science:

  • Child and Adolescent Psychiatry
  • Clinical Pharmacy
  • Public Health

Background:

  • Second-generation antipsychotics (SGAs) are increasingly prescribed for pediatric mental health conditions.
  • Metabolic monitoring is crucial for managing the side effects of SGAs in children.
  • Lack of standardized monitoring protocols can lead to suboptimal care.

Purpose of the Study:

  • To evaluate the impact of a Metabolic Monitoring Training Program (MMTP) on metabolic monitoring practices.
  • To assess changes in the prescription rates of SGAs for children post-MMTP implementation.
  • To determine the effectiveness of MMTP in an urban community-based mental health setting.

Main Methods:

  • Retrospective chart review of children treated at Vancouver Coastal Health Child and Youth Mental Health Teams (CYMHTs).
  • Data collected included demographics, diagnoses, and medication use, with a focus on SGA-treated children.
  • Anthropometric measurements and blood work data were analyzed at baseline and 3, 6, and 12 months post-implementation.

Main Results:

  • A significant reduction in SGA prescriptions was observed post-MMTP implementation (from 15.4% to 6.4% of children).
  • Metabolic monitoring rates increased significantly at baseline (up to 40%), 3 months (20%), and 6 months (20%) post-MMTP.
  • A trend towards improved monitoring was noted at 12 months, with 38.3% of SGA-treated children having the MMTP protocol in their chart.

Conclusions:

  • Implementation of an MMTP in urban community mental health clinics significantly improved metabolic monitoring for SGA-treated children.
  • The MMTP was associated with a substantial decrease in SGA prescriptions for pediatric patients.
  • These findings support the integration of structured training programs to enhance care quality for children on SGAs.
Abstract

More Related Videos

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Community Based Intervention01:30

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...